Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study
Resource Type
Article
Authors
Gaspar, Nathalie ; Venkatramani, Rajkumar ; Hecker-Nolting, Stefanie ; Melcon, Soledad Gallego ; Locatelli, Franco ; Bautista, Francisco ; Longhi, Alessandra ; Lervat, Cyril ; Entz-Werle, Natacha ; Casanova, Michela ; Aerts, Isabelle ; Strauss, Sandra J ; Thebaud, Estelle ; Morland, Bruce ; Nieto, Adela Cañete ; Marec-Berard, Perrine ; Gambart, Marion ; Rossig, Claudia ; Okpara, Chinyere E ; He, Cixin ; Dutta, Lea ; Campbell-Hewson, Quentin
Source
In The Lancet Oncology September 2021 22(9):1312-1321
Subject
Primary Research Articles
Language
ISSN
1470-2045